Navigation Links
Shanghai ChemPartner's Animal Facility Awarded AAALAC Accreditation
Date:3/1/2010

SHANGHAI, March 1 /PRNewswire-Asia/ -- Shanghai ChemPartner, a leading China-based contract research organization and a wholly-owned subsidiary of ShangPharma, today announced that its animal facility has received accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.

AAALAC International is a private, non-profit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. As a result of an extensive on-site evaluation, AAALAC determined that Shanghai ChemPartner's animal facility is committed to the highest level of animal care and research practices.

AAALAC noted the following in its official approval letter: "The Shanghai ChemPartner management and staff are commended for providing sound facilities and programs for the care and use of laboratory animals. Especially noteworthy were the strong administrative commitment to the program, as evidenced by the financial support for the three well maintained, state-of-the-art animal facilities and equipment, as well as the highly capable and qualified animal resources staff; the active, conscientious, capable and very knowledgeable Institutional Animal Care and Use Committee (IACUC); the knowledgeable and experienced animal care and use staff; the dedication of a team who worked extremely well together to ensure responsible and appropriate animal care and use; the excellent documentation (Standard Operating Procedures and guidelines) and records, with attention to detail and completeness; and the good animal health. Therefore, FULL ACCREDITATION is awarded."

"The AAALAC accreditation comes as a result of our efforts in expanding service capabilities from chemistry to preclinical drug development including in vivo pharmacology, drug metabolism and pharmacokinetics (DMPK) and toxicology," commented Michael Hui, founder and CEO of ChemPartner. "We are pleased to receive such high praise from the leading independent world body on the care and use of laboratory animals. We are confident of being an industry leader with the endorsement of AAALAC."

About Shanghai ChemPartner

Founded in 2003, Shanghai ChemPartner (ChemPartner) is one of the leading contract research organizations providing medicinal chemistry, discovery biology, pharmacology, DMPK, toxicology, process R&D, analytical development, formulation and contract manufacturing services to over 120 pharmaceutical and biotech companies in the world. ChemPartner currently has a team of over 1,000 scientists including more than 100 senior scientific leaders with extensive industry experiences gained from leading global pharmaceutical and biotech companies. Headquartered in China, ChemPartner has overseas business development operations in Boston, USA and Copenhagen, Denmark.

About ShangPharma

ShangPharma is a leading China-based outsourcing partner in pharmaceutical and biotechnology research and development, who provides customized services to international pharmaceutical, biotech, agrochemical and chemical companies. As the holding company of Shanghai ChemPartner Co., Ltd., Shanghai ChemExplorer Company Ltd., China Gateway Pharmaceutical (Shanghai) Ltd. and China Gateway Pharma Products (Chengdu) Ltd., ShangPharma offers global pharmaceutical, biotechnology and chemical companies comprehensive services and materials for their research and development needs. ShangPharma currently has a team of more than 1,800 professionals, and more than 60% of the employees have post graduate educational experience of Master or Ph.D. degrees. ShangPharma has established comprehensive R&D partnerships with world-class academic institutes, universities as well as healthcare industry and organizations, to contribute more added-value for its clients' success.

Further information is available at http://www.shangpharma.com .

About AAALAC International

AAALAC International is a private, non-profit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. AAALAC stands for the "Association for Assessment and Accreditation of Laboratory Animal Care."

More than 800 companies, universities, hospitals, government agencies and other research institutions in 32 countries have earned AAALAC accreditation, demonstrating their commitment to responsible animal care and use. These institutions volunteer to participate in AAALAC's program, in addition to complying with the local, state and federal laws that regulate animal research.

Further information is available at http://www.aaalac.org

SOURCE Shanghai ChemPartner

Back to top

RELATED LINKS
http://www.shangpharma.com
http://www.aaalac.org

'/>"/>

SOURCE Shanghai ChemPartner
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shanghai Century Acquisition Corporation Announces Sichuan Kelun Pharmaceutical Co Results for the Six Months Ended June 30, 2007
2. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
3. Cinpathogen Brings Together Over 40 Shanghai Area Hospitals at the First Annual Cinpathogen Hematology Conference
4. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
5. Shanghai CRO Service Alliance Adds Clinical Development Capabilities
6. Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company
7. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
8. NeoStem Signs Agreement with Shanghai Corporation to Develop A Stem Cell Collection and Treatment Network in Shanghai, Taiwan and Other Targeted China Provinces
9. Sundia and 2 Other CRO Companies Granted Express Customs Clearance Privilege in Shanghai
10. Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration
11. Sundia Shortens CRO Shipment Delivery Time with Express Customs Clearance in Shanghai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):